234 related articles for article (PubMed ID: 29176006)
1. GPR120: Mechanism of action, role and potential for medical applications.
Karakuła-Juchnowicz H; Róg J; Juchnowicz D; Morylowska-Topolska J
Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):942-953. PubMed ID: 29176006
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells.
Mobraten K; Haug TM; Kleiveland CR; Lea T
Lipids Health Dis; 2013 Jul; 12():101. PubMed ID: 23849180
[TBL] [Abstract][Full Text] [Related]
3. GPR120 agonists for the treatment of diabetes: a patent review (2014 present).
Zhang X; Macielag MJ
Expert Opin Ther Pat; 2020 Oct; 30(10):729-742. PubMed ID: 32799609
[TBL] [Abstract][Full Text] [Related]
4. Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages.
Im DS
Eur J Pharmacol; 2016 Aug; 785():36-43. PubMed ID: 25987421
[TBL] [Abstract][Full Text] [Related]
5. A novel anti-inflammatory role of GPR120 in intestinal epithelial cells.
Anbazhagan AN; Priyamvada S; Gujral T; Bhattacharyya S; Alrefai WA; Dudeja PK; Borthakur A
Am J Physiol Cell Physiol; 2016 Apr; 310(7):C612-21. PubMed ID: 26791484
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.
Wannick M; Bezdek S; Guillen N; Thieme M; Meshrkey F; Mousavi S; Seeling M; Nimmerjahn F; Mócsai A; Zillikens D; Sezin T; Sadik CD
Pharmacol Res Perspect; 2018 Dec; 6(6):e00438. PubMed ID: 30455959
[TBL] [Abstract][Full Text] [Related]
7. IL-1β and TNFα inhibit GPR120 (FFAR4) and stimulate GPR84 (EX33) and GPR41 (FFAR3) fatty acid receptor expression in human adipocytes: implications for the anti-inflammatory action of n-3 fatty acids.
Muredda L; Kępczyńska MA; Zaibi MS; Alomar SY; Trayhurn P
Arch Physiol Biochem; 2018 May; 124(2):97-108. PubMed ID: 28835131
[TBL] [Abstract][Full Text] [Related]
8. Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research.
Li A; Li Y; Du L
Future Med Chem; 2015; 7(11):1457-68. PubMed ID: 26230883
[TBL] [Abstract][Full Text] [Related]
9. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.
Oh DY; Walenta E; Akiyama TE; Lagakos WS; Lackey D; Pessentheiner AR; Sasik R; Hah N; Chi TJ; Cox JM; Powels MA; Di Salvo J; Sinz C; Watkins SM; Armando AM; Chung H; Evans RM; Quehenberger O; McNelis J; Bogner-Strauss JG; Olefsky JM
Nat Med; 2014 Aug; 20(8):942-7. PubMed ID: 24997608
[TBL] [Abstract][Full Text] [Related]
10. FFAR4 (GPR120) Signaling Is Not Required for Anti-Inflammatory and Insulin-Sensitizing Effects of Omega-3 Fatty Acids.
Pærregaard SI; Agerholm M; Serup AK; Ma T; Kiens B; Madsen L; Kristiansen K; Jensen BA
Mediators Inflamm; 2016; 2016():1536047. PubMed ID: 27999451
[TBL] [Abstract][Full Text] [Related]
11. Dietary Fatty Acids and Their Potential for Controlling Metabolic Diseases Through Activation of FFA4/GPR120.
Ulven T; Christiansen E
Annu Rev Nutr; 2015; 35():239-63. PubMed ID: 26185978
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic Acid Attenuates the Progression of Nonalcoholic Steatohepatitis by Suppressing the Adipocyte Inflammation via the G Protein-Coupled Receptor 120/Free Fatty Acid Receptor 4 Pathway.
Nakamoto K; Tokuyama S
Pharmacology; 2022; 107(5-6):330-338. PubMed ID: 35189618
[TBL] [Abstract][Full Text] [Related]
13. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human.
Ichimura A; Hirasawa A; Poulain-Godefroy O; Bonnefond A; Hara T; Yengo L; Kimura I; Leloire A; Liu N; Iida K; Choquet H; Besnard P; Lecoeur C; Vivequin S; Ayukawa K; Takeuchi M; Ozawa K; Tauber M; Maffeis C; Morandi A; Buzzetti R; Elliott P; Pouta A; Jarvelin MR; Körner A; Kiess W; Pigeyre M; Caiazzo R; Van Hul W; Van Gaal L; Horber F; Balkau B; Lévy-Marchal C; Rouskas K; Kouvatsi A; Hebebrand J; Hinney A; Scherag A; Pattou F; Meyre D; Koshimizu TA; Wolowczuk I; Tsujimoto G; Froguel P
Nature; 2012 Feb; 483(7389):350-4. PubMed ID: 22343897
[TBL] [Abstract][Full Text] [Related]
14. Potential roles of GPR120 and its agonists in the management of diabetes.
Zhang D; Leung PS
Drug Des Devel Ther; 2014; 8():1013-27. PubMed ID: 25114508
[TBL] [Abstract][Full Text] [Related]
15. GPR120 in adipocytes has differential roles in the production of pro-inflammatory adipocytokines.
Hasan AU; Ohmori K; Hashimoto T; Kamitori K; Yamaguchi F; Noma T; Igarashi J; Tsuboi K; Tokuda M; Nishiyama A; Kohno M
Biochem Biophys Res Commun; 2017 Apr; 486(1):76-82. PubMed ID: 28263744
[TBL] [Abstract][Full Text] [Related]
16. GPR120: a critical role in adipogenesis, inflammation, and energy metabolism in adipose tissue.
Song T; Yang Y; Zhou Y; Wei H; Peng J
Cell Mol Life Sci; 2017 Aug; 74(15):2723-2733. PubMed ID: 28285320
[TBL] [Abstract][Full Text] [Related]
17. FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation.
Im DS
Mol Aspects Med; 2018 Dec; 64():92-108. PubMed ID: 28887275
[TBL] [Abstract][Full Text] [Related]
18. The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity.
Oh DY; Lagakos WS
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):322-7. PubMed ID: 21587066
[TBL] [Abstract][Full Text] [Related]
19. The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120.
Bjursell M; Xu X; Admyre T; Böttcher G; Lundin S; Nilsson R; Stone VM; Morgan NG; Lam YY; Storlien LH; Lindén D; Smith DM; Bohlooly-Y M; Oscarsson J
PLoS One; 2014; 9(12):e114942. PubMed ID: 25541716
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Tool Compounds for the Free Fatty Acid Receptor 4 (FFA4/GPR120).
Hansen SV; Ulven T
Handb Exp Pharmacol; 2017; 236():33-56. PubMed ID: 27807695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
